Results 161 to 170 of about 123,936 (306)

Cost‐utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić   +4 more
wiley   +1 more source

Household’s willingness to pay for safe drinking water: A case study of Abbottabad district

open access: yes
This study is based on survey data and used both the contingent valuation method and averting behaviour approach to capture HH's willingness to pay for services and quality in the drinking water sector. In case of the HH’s WTP for improved water services,
Ahmad, Iftikhar   +2 more
core  

Willingness to Pay for Drug Rehabilitation: Implications for Cost Recovery [PDF]

open access: yes
Objectives: This study estimates the value that clients place on drug rehabilitation services at the time of intake and how this value varies with the probability of success and availability of social services.
Jody Sindelar, David Bishai
core  

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher   +7 more
wiley   +1 more source

Comparing Willingness-to-Pay Estimates from Experimental Auctions with Mailed Surveys Incorporating Cheap Talk

open access: yes
Willingness-to-pay (WTP) results from experimental auctions are compared to those from cheap-talk and conventional surveys for branded beef products in Canada. It is found that while the cheap-talk survey appears to mitigate hypothetical bias compared to
Froehlich, Eve J., Carlberg, Jared G.
core  

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer   +4 more
wiley   +1 more source

Consumers' Willingness to Pay for Genetically Modified Foods in Kenya

open access: yes
A survey of 600 consumers was conducted in Nairobi to determine attitudes and willingness to pay (WTP) for GM maize meal. WTP was estimated using the double-bounded logit model. Overall, 38% are aware of GM crops. Most consumers believe in the technology'
De Groote, Hugo, Kimenju, Simon Chege
core  

Home - About - Disclaimer - Privacy